PMID- 37349472 OWN - NLM STAT- MEDLINE DCOM- 20231023 LR - 20231026 IS - 1740-634X (Electronic) IS - 0893-133X (Print) IS - 0893-133X (Linking) VI - 48 IP - 12 DP - 2023 Nov TI - Deficits in integrative NMDA receptors caused by Grin1 disruption can be rescued in adulthood. PG - 1742-1751 LID - 10.1038/s41386-023-01619-y [doi] AB - Glutamatergic NMDA receptors (NMDAR) are critical for cognitive function, and their reduced expression leads to intellectual disability. Since subpopulations of NMDARs exist in distinct subcellular environments, their functioning may be unevenly vulnerable to genetic disruption. Here, we investigate synaptic and extrasynaptic NMDARs on the major output neurons of the prefrontal cortex in mice deficient for the obligate NMDAR subunit encoded by Grin1 and wild-type littermates. With whole-cell recording in brain slices, we find that single, low-intensity stimuli elicit surprisingly-similar glutamatergic synaptic currents in both genotypes. By contrast, clear genotype differences emerge with manipulations that recruit extrasynaptic NMDARs, including stronger, repetitive, or pharmacological stimulation. These results reveal a disproportionate functional deficit of extrasynaptic NMDARs compared to their synaptic counterparts. To probe the repercussions of this deficit, we examine an NMDAR-dependent phenomenon considered a building block of cognitive integration, basal dendrite plateau potentials. Since we find this phenomenon is readily evoked in wild-type but not in Grin1-deficient mice, we ask whether plateau potentials can be restored by an adult intervention to increase Grin1 expression. This genetic manipulation, previously shown to restore cognitive performance in adulthood, successfully rescues electrically-evoked basal dendrite plateau potentials after a lifetime of NMDAR compromise. Taken together, our work demonstrates NMDAR subpopulations are not uniformly vulnerable to the genetic disruption of their obligate subunit. Furthermore, the window for functional rescue of the more-sensitive integrative NMDARs remains open into adulthood. CI - (c) 2023. The Author(s). FAU - Venkatesan, Sridevi AU - Venkatesan S AD - Department of Physiology, University of Toronto, Toronto, ON, Canada. FAU - Binko, Mary A AU - Binko MA AD - Department of Physiology, University of Toronto, Toronto, ON, Canada. AD - University of Pittsburgh Medical Center, Pittsburgh, PA, USA. FAU - Mielnik, Catharine A AU - Mielnik CA AD - Department of Pharmacology and Toxicology, University of Toronto, Toronto, ON, Canada. FAU - Ramsey, Amy J AU - Ramsey AJ AUID- ORCID: 0000-0002-2717-5279 AD - Department of Physiology, University of Toronto, Toronto, ON, Canada. AD - Department of Pharmacology and Toxicology, University of Toronto, Toronto, ON, Canada. FAU - Lambe, Evelyn K AU - Lambe EK AUID- ORCID: 0000-0002-5994-6090 AD - Department of Physiology, University of Toronto, Toronto, ON, Canada. evelyn.lambe@utoronto.ca. AD - Department of OBGYN, University of Toronto, Toronto, ON, Canada. evelyn.lambe@utoronto.ca. AD - Department of Psychiatry, University of Toronto, Toronto, ON, Canada. evelyn.lambe@utoronto.ca. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20230622 PL - England TA - Neuropsychopharmacology JT - Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology JID - 8904907 RN - 0 (Receptors, N-Methyl-D-Aspartate) SB - IM MH - Mice MH - Animals MH - *Receptors, N-Methyl-D-Aspartate/genetics/metabolism MH - *Neurons/metabolism MH - Prefrontal Cortex/metabolism MH - Synapses/metabolism PMC - PMC10579298 COIS- The authors declare no competing interests. EDAT- 2023/06/23 01:10 MHDA- 2023/10/23 00:42 PMCR- 2023/06/22 CRDT- 2023/06/22 23:22 PHST- 2022/11/22 00:00 [received] PHST- 2023/05/22 00:00 [accepted] PHST- 2023/05/10 00:00 [revised] PHST- 2023/10/23 00:42 [medline] PHST- 2023/06/23 01:10 [pubmed] PHST- 2023/06/22 23:22 [entrez] PHST- 2023/06/22 00:00 [pmc-release] AID - 10.1038/s41386-023-01619-y [pii] AID - 1619 [pii] AID - 10.1038/s41386-023-01619-y [doi] PST - ppublish SO - Neuropsychopharmacology. 2023 Nov;48(12):1742-1751. doi: 10.1038/s41386-023-01619-y. Epub 2023 Jun 22.